Human head and neck Vitreomacular adhesion

Intravitreal gas for symptomatic vitreomacular adhesion: a synthesis of the literatureIntravitreal gas for symptomatic vitreomacular adhesion: a synthesis of the literature
James E. Neffendorf mbbs 1,2, Andrew R. H. Simpson mbbs 2, David H. W. Steel frcophth3,4, Riti Desai mphil 2,5, Dominic A. McHugh frcophth 5, Edward Pringle frcophth 5, and Timothy L. Jackson frcophth 2,5. Vitreomacular adhesion
49.04 Kb. 1
read
7. 07 ocriplasmin intravitreal injection, 5 mg/2 mL, Jetrea®, Alcon7. 07 ocriplasmin intravitreal injection, 5 mg/2 mL, Jetrea®, Alcon
The first and only previous submission was an integrated co-dependent submission considered in November 2014. Vitreomacular adhesion
386.53 Kb. 6
read
30th Anniversary Annual Scientific Meeting of the American Society of Retina Specialists30th Anniversary Annual Scientific Meeting of the American Society of Retina Specialists
The American Society of Retina Specialists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Vitreomacular adhesion
92.78 Kb. 1
read
Eye condition fact sheet Light sensitivity: PhotophobiaEye condition fact sheet Light sensitivity: Photophobia
A macular hole affects your central vision, making it distorted and blurred so that it’s more difficult for you to do things like read and watch television. You may also have a blank patch in the centre of your vision. Vitreomacular adhesion
269.37 Kb. 1
read
Public Summary Document Application No. 1370. 1Public Summary Document Application No. 1370. 1
Application No. 1370. 1 – Ocriplasmin for symptomatic vitreomacular adhesion (vma) including macular hole. Vitreomacular adhesion
72.62 Kb. 1
read
1370 Final Protocol to guide the assessment of optical coherence tomography for the determination of eligibility and efficacy assessment of treatment with ocriplasmin (jetrea®)1370 Final Protocol to guide the assessment of optical coherence tomography for the determination of eligibility and efficacy assessment of treatment with ocriplasmin (jetrea®)
Final Protocol to guide the assessment of optical coherence tomography for the determination of eligibility and efficacy assessment of treatment with ocriplasmin (jetrea®). Vitreomacular adhesion
2.25 Mb. 5
read
Alan g. Kabat, od, faao memphis, tnAlan g. Kabat, od, faao memphis, tn
Course Description: The speakers present a variety of groundbreaking new diagnostic and therapeutic strategies for numerous conditions, including ocular surface disease, glaucoma and retinal disease in a rapid-fire, panel discussion format. Vitreomacular adhesion
342.32 Kb. 4
read
ThromboGenics\ThromboGenics' jetrea receives Positive Recommendation from Scottish Medicines Consortium (smc) Leuven, August 11, 2014
Edicines, today announces that the Scottish Medicines Consortium (smc) has issued a positive recommendation for the use of jetrea®. Vitreomacular adhesion
31.7 Kb. 1
read
When a pvd is not \When a pvd is not 'Just a pvd': Posterior Vitreous Detachment and its
Three-dimensional arrangement of structural molecules, i e collagen and hyaluronic acid, allow for stability of the semi-solid framework. Vitreomacular adhesion
27.33 Kb. 1
read

  1


The database is protected by copyright ©dentisty.org 2016
send message

    Main page